SlideShare a Scribd company logo
1 of 8
Download to read offline
#2- Date: 19-Dec-03




                                         MEAL SCHEDULE
                WAS THE    MEAL                                                                START TIME                            WAS THE   MEAL
  MEAL          ADMINISTERED?
                                               DATE        OF MEAL                                                                    COMPLETED?
                                                                                               STOP TIME                              (MARK   ONE)
                  (MARK   ONE)
                                                                                                       24   HR. CLOCK




                                                                                                   H     H     M M
            0       NO 1         YES                                                                   24 HR. CLOCK
                                                                                                                                 0     NO 1          YES
                                          D    D       M       M       M       Y       Y

                                                                                                   H    H          M    M




                                         MEAL SCHEDULE
                        WAS THE    MEAL                                                                 START TIME                   WAS THE    MEAL
 MEAL      RELATIVE     ADMINISTERED?                      DATE            OF MEAL                                                    COMPLETED?
             TIME                                                                                       STOP TIME
                          (MARK   ONE)                                                                                                (MARK    ONE)

                                                                                                            24   HR. CLOCK




HIGH-FAT     AM     0      NO 1          YES       D       D       M       M       M       Y   Y        H      H     M M         0      NO 1          YES
                                                                                                             24 HR. CLOCK


                                                                                                        H      H        M    M
STUDY MEDICATION
WAS A NEW     STUDY MEDICATION KIT DISPENSED?                0       NO   1      YES

      KIT NUMBER        DISPENSED AT THIS VISIT:

DATE AND TIME      OF DOSE TAKEN AT THIS VISIT:

              DATE                                    TIME                      NUMBER TAKEN   PER BOTTLE




                                                                                                              SMEDDISP006
                                                24   HR. CLOCK                BOTTLE A             BOTTLE B

  D   D   M    M    M    Y   Y              H    H       M       M
OTHER TREATMENT
IS THE   SUBJECT IN DOSE GROUP   2?    0       NO     1   YES       IF YES,   COMPLETE BELOW

    TREATMENT             WAS    DOSE ADMINISTERED?             DATE    OF    DOSE        TIME     OF   DOSE
                                                                                              24   HR. CLOCK


RITONAVIR 200 mg          0       NO       1        YES
                                                            D   D   M   M     M   Y   Y   H    H        M      M
DOSING - DAY 1

    START DATE     OF INFUSION          START TIME      OF INFUSION         STOP DATE    OF INFUSION      STOP TIME     OF INFUSION
                                                  24   HR. CLOCK                                                  24   HR. CLOCK




     D     D   M   M   M       Y    Y         H    H        M      M        D   D    M   M    M   Y   Y       H    H       M       M

D                                               WEIGHT OF
A
    TOTAL DOSE     DELIVERED                INFUSATE DELIVERED
Y

1                              mg                                      g

    SITE   OF INFUSION:
                       1            LEFT ARM                    2          RIGHT ARM
                       3            CENTRAL LINE             98        OTHER (SPECIFY)



                                                  DOSING CHANGES
                                                                                     S
                                                                           NO

                                                                                    YE
                                                                                             REASON               SPECIFY
                                                                            0        1
     WAS    DOSE OMITTED?
D
A
Y    WAS THE INFUSION TEMPORARILY INTERRUPTED?
      INTERRUPTION DURATION:
1

                           1        MIN       2           HR




                                        DOSE OMITTED REASONS
                                         9 = DELAYED HEMATOLOGIC RECOVERY
                                        12 = DELAYED NON-HEMATOLOGIC RECOVERY (SPECIFY)
                                        98 = OTHER (SPECIFY)

                                        INFUSION INTERRUPTED REASONS
                                          8 = HYPERSENSITIVITY REACTION
                                        17 = ADVERSE EVENT (SPECIFY)
                                        98 = OTHER (SPECIFY)
RECORD OF STUDY MEDICATION
WAS THE   DOSE ADMINISTERED?   0   NO       1       YES


          TREATMENT                         DATE    OF   DOSE         TIME      OF   DOSE

                                                                           24   HR. CLOCK
A           B          C
                                        D   D   M   M     M   Y   Y    H     H       M      M
RECORD OF STUDY MEDICATION

    WAS THE   DOSE ADMINISTERED?   0       NO       1       YES


    DOSE GROUP                             DATE     OF DOSE           TIME      OF DOSE
     (MARK ONE)
                                                                          24   HR. CLOCK
1        2         3
4        5         6                   D   D    M   M   M   Y     Y   H    H       M       M
RECORD OF STUDY MEDICATION

          TREATMENT                             DATE   OF DOSE           TIME      OF DOSE



                                                                              24   HR. CLOCK

     BMS-298585 10 mg
                                        D   D     M    M   M    Y    Y    H       H       M       M



                      RECORD OF STUDY MEDICATION

     WAS THE   DOSE ADMINISTERED?   0       NO         1       YES


      TREATMENT                             DATE      OF DOSE             TIME         OF DOSE



                                                                                  24   HR. CLOCK



                                        D   D    M     M   M    Y    Y        H       H       M       M



                      RECORD OF STUDY MEDICATION

WAS THE   DOSE ADMINISTERED?                    DATE   OF DOSE           TIME      OF     DOSE

                                                                                  24   HR. CLOCK
 0        NO    1     YES
                                        D   D    M     M   M   Y     Y        H       H    M       M
DRUG ADMINISTRATION

           WAS THE    DOSE ADMINISTERED?    0        NO       1     YES


                                                                        START TIME               STOP TIME
          TREATMENT              DATE ADMINISTERED?
                                                                        OF INFUSION              OF INFUSION


                                                                            24   HR. CLOCK           24   HR. CLOCK

      A        B
                                D   D   M   M    M   Y    Y             H    H       M       M   H    H       M       M


WAS   FULL INFUSION COMPLETED?      0       NO            1       YES

TOTAL DOSE ADMINISTERED?                                  mg

More Related Content

Viewers also liked (20)

My new title
My new titleMy new title
My new title
 
Ebr Smp
Ebr  SmpEbr  Smp
Ebr Smp
 
Ebr Smp
Ebr  SmpEbr  Smp
Ebr Smp
 
Medio Ambiente
Medio AmbienteMedio Ambiente
Medio Ambiente
 
Redes Informaticas
Redes InformaticasRedes Informaticas
Redes Informaticas
 
Fredias Presentation
Fredias PresentationFredias Presentation
Fredias Presentation
 
Leanna, Eleni and Raquel\'s URL Mini Assignment
Leanna, Eleni and Raquel\'s URL Mini AssignmentLeanna, Eleni and Raquel\'s URL Mini Assignment
Leanna, Eleni and Raquel\'s URL Mini Assignment
 
Hopeleehats
HopeleehatsHopeleehats
Hopeleehats
 
Lo que cuesta una novia en Cali
Lo que cuesta una novia en CaliLo que cuesta una novia en Cali
Lo que cuesta una novia en Cali
 
Opaque
OpaqueOpaque
Opaque
 
Sobre Carod Rovira
Sobre Carod RoviraSobre Carod Rovira
Sobre Carod Rovira
 
EMC Basada En La Web 2.0
EMC Basada En La Web 2.0EMC Basada En La Web 2.0
EMC Basada En La Web 2.0
 
Searching by Advanced Keyword
Searching by Advanced KeywordSearching by Advanced Keyword
Searching by Advanced Keyword
 
Citrin08
Citrin08Citrin08
Citrin08
 
Mozilla Mexico FONASOL 2008
Mozilla Mexico FONASOL 2008Mozilla Mexico FONASOL 2008
Mozilla Mexico FONASOL 2008
 
Historiafotografia
HistoriafotografiaHistoriafotografia
Historiafotografia
 
Introduccion A Informatica
Introduccion A InformaticaIntroduccion A Informatica
Introduccion A Informatica
 
El Vino
El VinoEl Vino
El Vino
 
Show me the Moodle - An Orientation to RETA Moodle
Show me the Moodle - An Orientation to RETA MoodleShow me the Moodle - An Orientation to RETA Moodle
Show me the Moodle - An Orientation to RETA Moodle
 
Amazonia, ame preservando e respeitando (em inglês)
Amazonia, ame preservando e respeitando (em inglês)Amazonia, ame preservando e respeitando (em inglês)
Amazonia, ame preservando e respeitando (em inglês)
 

Recently uploaded

Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreternaman860154
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationSafe Software
 
Artificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraArtificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraDeakin University
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationRidwan Fadjar
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptxLBM Solutions
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationSlibray Presentation
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 3652toLead Limited
 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Scott Keck-Warren
 
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptxMaking_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptxnull - The Open Security Community
 
Pigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions
 
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Patryk Bandurski
 
Unblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesUnblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesSinan KOZAK
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
 
Injustice - Developers Among Us (SciFiDevCon 2024)
Injustice - Developers Among Us (SciFiDevCon 2024)Injustice - Developers Among Us (SciFiDevCon 2024)
Injustice - Developers Among Us (SciFiDevCon 2024)Allon Mureinik
 
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | DelhiFULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhisoniya singh
 

Recently uploaded (20)

DMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special EditionDMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special Edition
 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
 
Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreter
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
 
Artificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraArtificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning era
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 Presentation
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptx
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck Presentation
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024
 
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptxMaking_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
 
Pigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food Manufacturing
 
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
 
Unblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesUnblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen Frames
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
 
The transition to renewables in India.pdf
The transition to renewables in India.pdfThe transition to renewables in India.pdf
The transition to renewables in India.pdf
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
 
Injustice - Developers Among Us (SciFiDevCon 2024)
Injustice - Developers Among Us (SciFiDevCon 2024)Injustice - Developers Among Us (SciFiDevCon 2024)
Injustice - Developers Among Us (SciFiDevCon 2024)
 
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | DelhiFULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
 

Meal And Smed Modules Part Two

  • 1. #2- Date: 19-Dec-03 MEAL SCHEDULE WAS THE MEAL START TIME WAS THE MEAL MEAL ADMINISTERED? DATE OF MEAL COMPLETED? STOP TIME (MARK ONE) (MARK ONE) 24 HR. CLOCK H H M M 0 NO 1 YES 24 HR. CLOCK 0 NO 1 YES D D M M M Y Y H H M M MEAL SCHEDULE WAS THE MEAL START TIME WAS THE MEAL MEAL RELATIVE ADMINISTERED? DATE OF MEAL COMPLETED? TIME STOP TIME (MARK ONE) (MARK ONE) 24 HR. CLOCK HIGH-FAT AM 0 NO 1 YES D D M M M Y Y H H M M 0 NO 1 YES 24 HR. CLOCK H H M M
  • 2. STUDY MEDICATION WAS A NEW STUDY MEDICATION KIT DISPENSED? 0 NO 1 YES KIT NUMBER DISPENSED AT THIS VISIT: DATE AND TIME OF DOSE TAKEN AT THIS VISIT: DATE TIME NUMBER TAKEN PER BOTTLE SMEDDISP006 24 HR. CLOCK BOTTLE A BOTTLE B D D M M M Y Y H H M M
  • 3. OTHER TREATMENT IS THE SUBJECT IN DOSE GROUP 2? 0 NO 1 YES IF YES, COMPLETE BELOW TREATMENT WAS DOSE ADMINISTERED? DATE OF DOSE TIME OF DOSE 24 HR. CLOCK RITONAVIR 200 mg 0 NO 1 YES D D M M M Y Y H H M M
  • 4. DOSING - DAY 1 START DATE OF INFUSION START TIME OF INFUSION STOP DATE OF INFUSION STOP TIME OF INFUSION 24 HR. CLOCK 24 HR. CLOCK D D M M M Y Y H H M M D D M M M Y Y H H M M D WEIGHT OF A TOTAL DOSE DELIVERED INFUSATE DELIVERED Y 1 mg g SITE OF INFUSION: 1 LEFT ARM 2 RIGHT ARM 3 CENTRAL LINE 98 OTHER (SPECIFY) DOSING CHANGES S NO YE REASON SPECIFY 0 1 WAS DOSE OMITTED? D A Y WAS THE INFUSION TEMPORARILY INTERRUPTED? INTERRUPTION DURATION: 1 1 MIN 2 HR DOSE OMITTED REASONS 9 = DELAYED HEMATOLOGIC RECOVERY 12 = DELAYED NON-HEMATOLOGIC RECOVERY (SPECIFY) 98 = OTHER (SPECIFY) INFUSION INTERRUPTED REASONS 8 = HYPERSENSITIVITY REACTION 17 = ADVERSE EVENT (SPECIFY) 98 = OTHER (SPECIFY)
  • 5. RECORD OF STUDY MEDICATION WAS THE DOSE ADMINISTERED? 0 NO 1 YES TREATMENT DATE OF DOSE TIME OF DOSE 24 HR. CLOCK A B C D D M M M Y Y H H M M
  • 6. RECORD OF STUDY MEDICATION WAS THE DOSE ADMINISTERED? 0 NO 1 YES DOSE GROUP DATE OF DOSE TIME OF DOSE (MARK ONE) 24 HR. CLOCK 1 2 3 4 5 6 D D M M M Y Y H H M M
  • 7. RECORD OF STUDY MEDICATION TREATMENT DATE OF DOSE TIME OF DOSE 24 HR. CLOCK BMS-298585 10 mg D D M M M Y Y H H M M RECORD OF STUDY MEDICATION WAS THE DOSE ADMINISTERED? 0 NO 1 YES TREATMENT DATE OF DOSE TIME OF DOSE 24 HR. CLOCK D D M M M Y Y H H M M RECORD OF STUDY MEDICATION WAS THE DOSE ADMINISTERED? DATE OF DOSE TIME OF DOSE 24 HR. CLOCK 0 NO 1 YES D D M M M Y Y H H M M
  • 8. DRUG ADMINISTRATION WAS THE DOSE ADMINISTERED? 0 NO 1 YES START TIME STOP TIME TREATMENT DATE ADMINISTERED? OF INFUSION OF INFUSION 24 HR. CLOCK 24 HR. CLOCK A B D D M M M Y Y H H M M H H M M WAS FULL INFUSION COMPLETED? 0 NO 1 YES TOTAL DOSE ADMINISTERED? mg